Shares of Trulieve Cannabis Corp TCNNF were down Monday after the Florida company reported third-quarter results.
The company, which started trading on the Canadian Securities Exchange and U.S. OTC market in September, saw higher revenue and EBITDA during the quarter.
What Happened
Trulieve's Q3 revenue of $28.3 million is higher by almost 43 percent on the year compared to the $19.8 million posted for the same period of 2017.
The company's net income under IFRS surged from $7.9 million in Q2 to $17.5 million. Trulieve's earnings before interest, taxes, depreciation, and amortization increased from $800,000 a year earlier and $11.7 million in Q2 to $12.6 million.
At the same time, the company's gross margin declined by 4.9 percentage points to 70.5 percent quarter-over-quarter, but increased from 43.9 percent a year earlier.
Why It's Important
Trulieve is one of the largest cannabis companies in Florida and is the first fully licensed medical marijuana producer and retailer that cultivates cannabis, processes and distributes it through its own branded chain of dispensaries and home deliveries in the state. The company operates 21 dispensaries.
What's Next
Trulieve recently announced plans to expand its operations outside of Florida and into other states. The company has acquired Life Essence and Leef Industries, giving it exposure to the Massachusetts and California markets.
"We believe we are well-positioned in continuing to be the dominant leader in the Florida market while firmly establishing our footprint in the Massachusetts and California markets moving forward," CEO Kim Rivers said in a statement.
Trulieve's OTC-traded shares were down 9.92 percent at $11.17 at the time of publication Monday.
Related Links:
First Recreational Cannabis Stores In Massachusetts To Open Tuesday
Cannabis Earnings Roundup: Record Sales, But Concerns Remain
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!